NASDAQ:BLCM
Bellicum Pharmaceuticals Stock News
$0.0748
+0 (+0%)
At Close: Apr 30, 2024
Edited Transcript of BLCM earnings conference call or presentation 12-Mar-20 9:00pm GMT
02:55pm, Tuesday, 31'st Mar 2020
Q4 2019 Bellicum Pharmaceuticals Inc Earnings Call
Mar 20, 2020 (The Expresswire) --
Global “Bone Marrow Transplant Rejection Treatment Market” Report 2020 is a comprehensive, professional report provides a...
144 Biggest Movers From Friday
09:03am, Monday, 16'th Mar 2020
Gainers
Contura Energy, Inc. (NYSE: CTRA) shares surged 64.7% to close at $4.89 on Friday. Contura is expected to release Q4 results on March 18.
Exterran Corporation (NYSE: EXTN...
Mid-Afternoon Market Update: Dow Surges Over 800 Points; Amyris Shares Slide
06:31pm, Friday, 13'th Mar 2020
Toward the end of trading Friday, the Dow traded up 3.84% to 22,013.72 while the NASDAQ rose 3.32% to 7,440.54. The S&P also rose, gaining 3.69% to 2,572.16. South Korea...
88 Stocks Moving In Friday's Mid-Day Session
04:38pm, Friday, 13'th Mar 2020
Gainers
CorePoint Lodging Inc. (NYSE: CPLG) gained 55.6% to $5.29 after the company reported results for its fourth quarter.
OPKO Health, Inc. (NASDAQ: OPK) climbed 44.4% to $2....
Mid-Day Market Update: Citi Trends Rises After Q4 Results; Inovio Pharmaceuticals Shares Plunge
04:10pm, Friday, 13'th Mar 2020
Midway through trading Friday, the Dow traded up 2.26% to 21680.64 while the NASDAQ rose 2.22% to 7,361.97. The S&P also rose, gaining 2.25% to 2,536.54. South Korea confirmed...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Bellicum Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Operational Update
08:05pm, Thursday, 12'th Mar 2020
Presented new Phase 1 translational results for BPX-601 at ASCO GI Initiated new GoCAR-NK™ program targeting BCMA Entered into asset purchase agreement and licensed technology.
Bellicum Pharmaceuticals, Inc. to Host Earnings Call
07:00pm, Thursday, 12'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 12, 2020 / Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 12, 2
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Bi
Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) Insiders Increased Their Holdings
10:48am, Tuesday, 10'th Mar 2020
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...